BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21455856)

  • 1. Thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance.
    Di Fabio F; Lykoudis P; Gordon PH
    Semin Thromb Hemost; 2011 Apr; 37(3):220-5. PubMed ID: 21455856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
    Koutroubakis IE
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-abdominal venous and arterial thromboembolism in inflammatory bowel disease.
    Di Fabio F; Obrand D; Satin R; Gordon PH
    Dis Colon Rectum; 2009 Feb; 52(2):336-42. PubMed ID: 19279432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local thrombolysis: a newer approach to treating inflammatory bowel disease-related thromboembolism.
    Tabibian JH; Roth BE
    J Clin Gastroenterol; 2009; 43(5):391-8. PubMed ID: 19247203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
    Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
    Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease.
    Zitomersky NL; Levine AE; Atkinson BJ; Harney KM; Verhave M; Bousvaros A; Lightdale JR; Trenor CC
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):343-7. PubMed ID: 23752078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
    Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H
    Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased risk of venous thromboembolism and arterial cardiovascular events in patients with inflammatory bowel disease].
    Lund Kristensen S; Ahlehoff O; Lindhardsen J; Gislason G; Nielsen OH; Hansen PR
    Ugeskr Laeger; 2012 Nov; 174(48):3003-6. PubMed ID: 23195352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombophilic conditions in the pathogenesis of venous thromboembolism].
    Poul H
    Vnitr Lek; 2006 Mar; 52 Suppl 1():17-25. PubMed ID: 16637445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.
    Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease.
    Guédon C; Le Cam-Duchez V; Lalaude O; Ménard JF; Lerebours E; Borg JY
    Am J Gastroenterol; 2001 May; 96(5):1448-54. PubMed ID: 11374681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.
    Sonoda K; Ikeda S; Mizuta Y; Miyahara Y; Kohno S
    J Gastroenterol; 2004 Oct; 39(10):948-54. PubMed ID: 15549447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in travellers: can we identify those at risk?
    McQuillan AD; Eikelboom JW; Baker RI
    Blood Coagul Fibrinolysis; 2003 Oct; 14(7):671-5. PubMed ID: 14517493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies.
    Fumery M; Xiaocang C; Dauchet L; Gower-Rousseau C; Peyrin-Biroulet L; Colombel JF
    J Crohns Colitis; 2014 Jun; 8(6):469-79. PubMed ID: 24183231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deep-vein thrombosis and pulmonary embolism due to air travel].
    Levi M; Rosendaal FR; Büller HR
    Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2474-8. PubMed ID: 17137092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
    Spina L; Saibeni S; Battaglioli T; Peyvandi F; de Franchis R; Vecchi M
    Am J Gastroenterol; 2005 Sep; 100(9):2036-41. PubMed ID: 16128949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.